192 related articles for article (PubMed ID: 36186907)
21. Overexpressed SNRPB/D1/D3/E/F/G correlate with poor survival and immune infiltration in hepatocellular carcinoma.
Li FP; Liu GH; Zhang XQ; Kong WJ; Mei J; Wang M; Dai YH
Am J Transl Res; 2022; 14(6):4207-4228. PubMed ID: 35836882
[TBL] [Abstract][Full Text] [Related]
22. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
23. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
[TBL] [Abstract][Full Text] [Related]
24. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
25. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
Front Genet; 2022; 13():965805. PubMed ID: 36159990
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
27. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
[TBL] [Abstract][Full Text] [Related]
28. An Integrated Analysis of the Identified PRPF19 as an Onco-immunological Biomarker Encompassing the Tumor Microenvironment, Disease Progression, and Prognoses in Hepatocellular Carcinoma.
Yang M; Qiu Y; Yang Y; Wang W
Front Cell Dev Biol; 2022; 10():840010. PubMed ID: 35252202
[No Abstract] [Full Text] [Related]
29. Component with abundant immune-related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis.
Yagi N; Suzuki T; Mizuno S; Kojima M; Kudo M; Sugimoto M; Kobayashi S; Gotohda N; Ishii G; Nakatsura T
Cancer Sci; 2022 May; 113(5):1564-1574. PubMed ID: 35226764
[TBL] [Abstract][Full Text] [Related]
30. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma.
Chen YR; Ouyang SS; Chen YL; Li P; Xu HW; Zhu SL
Aging (Albany NY); 2020 Sep; 12(17):17541-17567. PubMed ID: 32927435
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
[TBL] [Abstract][Full Text] [Related]
32. Tubulin Alpha 1b Is Associated with the Immune Cell Infiltration and the Response of HCC Patients to Immunotherapy.
Hu X; Zhu H; Chen B; He X; Shen Y; Zhang X; Chen W; Liu X; Xu Y; Xu X
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453905
[TBL] [Abstract][Full Text] [Related]
33. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma.
Che Y; Wang G; Xia Q
Front Genet; 2022; 13():937310. PubMed ID: 36105112
[No Abstract] [Full Text] [Related]
34. ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle.
Zhen J; Ke Y; Pan J; Zhou M; Zeng H; Song G; Yu Z; Fu B; Liu Y; Huang D; Wu H
Aging (Albany NY); 2022 Oct; 14(20):8411-8436. PubMed ID: 36287187
[TBL] [Abstract][Full Text] [Related]
35. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.
Li Z; Wang R; Qiu C; Cao C; Zhang J; Ge J; Shi Y
Front Immunol; 2022; 13():834606. PubMed ID: 35392073
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis.
Liu L; Wang Q; Wu L; Zhang L; Huang Y; Yang H; Guo L; Fang Z; Wang X
Cancer Cell Int; 2023 Jul; 23(1):138. PubMed ID: 37452331
[TBL] [Abstract][Full Text] [Related]
37. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
Front Oncol; 2021; 11():721644. PubMed ID: 34631549
[TBL] [Abstract][Full Text] [Related]
38. PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration.
Liu X; Zhang Y; Wang Z; Liu L; Zhang G; Li J; Ren Z; Dong Z; Yu Z
J Hepatocell Carcinoma; 2021; 8():1495-1511. PubMed ID: 34881207
[TBL] [Abstract][Full Text] [Related]
39. Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma.
Xiao Q; Cheng Z; Kuang W; Wu H; Luo X; Wang R
Appl Bionics Biomech; 2022; 2022():8926221. PubMed ID: 35126665
[TBL] [Abstract][Full Text] [Related]
40. High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
Front Oncol; 2022; 12():953529. PubMed ID: 36059705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
